myelinose

Myelinose refers to a pathological condition characterized by the degeneration or loss of myelin, the fatty substance that surrounds nerve fibers in the central and peripheral nervous systems. Myelin acts as an insulating layer, facilitating rapid electrical signal transmission along neurons. When damaged, it disrupts nerve function, leading to various neurological symptoms.

The term is often used interchangeably with demyelination, though myelinose can also describe congenital or hereditary conditions where myelin formation is impaired from birth. In acquired forms, myelin damage may result from autoimmune processes (such as multiple sclerosis), infections, toxins, nutritional deficiencies (e.g., vitamin B12 deficiency), or metabolic disorders. Symptoms depend on the affected nerves but commonly include muscle weakness, numbness, tingling, vision problems, or cognitive decline.

Myelinose can occur in both the central nervous system (CNS), including the brain and spinal cord, and the peripheral nervous system (PNS), affecting nerves outside the CNS. In the CNS, demyelination disrupts communication between neurons, while in the PNS, it impairs signal transmission from the body to the brain. Diagnosis typically involves imaging (MRI), nerve conduction studies, or spinal fluid analysis.

Treatment focuses on addressing the underlying cause, such as immunosuppressive therapy for autoimmune conditions or vitamin supplementation for deficiencies. Physical therapy and assistive devices may help manage symptoms. Early intervention can slow progression and improve outcomes, though some forms of myelinose are progressive and incurable. Research continues into regenerative therapies aimed at repairing myelin damage.